NEUROPACE INC

NEUROPACE INC

NeuroPace develops and commercializes brain neuromodulation technology for individuals with medically refractory epilepsy and other neurological conditions.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts recommend buying NeuroPace's stock, expecting its price to rise in the future.

Above Average

Financial Health

NeuroPace is performing well with strong revenue and cash flow, indicating healthy financial operations.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring NPCE

Wearable Health Stocks: Growth Potential vs Competition

Wearable Health Stocks: Growth Potential vs Competition

Apple's recent FDA clearance for its Apple Watch hypertension feature marks a major step in wearable medical technology. This development opens up investment opportunities in the broader ecosystem of connected health devices and remote patient monitoring services.

Published: September 12, 2025

Explore Basket
Brain-Computer Interface

Brain-Computer Interface

This collection features pioneering companies creating revolutionary pathways between the human brain and machines. These carefully selected stocks represent the cutting edge of neural technology, with potential to transform healthcare and computing through innovative brain signal interpretation.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

Responsive Neurostimulation

The RNS System’s closed‑loop approach targets seizures as they start, a clinical differentiation worth watching — though outcomes and adoption can vary.

📈

Adoption & Reimbursement

Broader use depends on referrals, training and payer coverage; improvements could support revenue, but reimbursement remains a key uncertainty.

🌍

Clinical Evidence Path

Long‑term data and potential label expansions influence the market opportunity, yet regulatory hurdles and competition may affect timelines.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

ABT

Abbott Laboratories

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

TMO

Thermo Fisher Scientific, Inc.

Thermo Fisher provides a range of services and products that help customers advance their research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.

ISRG

Intuitive Surgical, Inc.

A healthcare company that develops, manufactures, and markets robotic-assisted surgical systems for procedures in multiple specialties

Frequently asked questions